A recent qPCR study reported low iNOS mRNA expression in 95% of primary melanoma samples, contrasting with earlier IHC-based findings that suggested high iNOS expression in metastatic melanoma (Ekmekcioglu et al., 2006; Dabbeche-Bouricha et al., 2016). This evidence concerns the gene NOS2 and metastatic melanoma.